SCHEMBL9890002

SCHEMBL9890002

c1ccc(-c2cc(-c3ccc4c(c3)oc3cc5oc6cc(-c7ccc8c(c7)c7ccccc7n8-c7ccccc7)ccc6c5cc34)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
ATM Q13315 1/20 0.38
MAPT P10636 7/20 0.36
MEN1 O00255 6/20 0.36
KMT2A Q03164 6/20 0.36
ALDH1A1 P00352 6/20 0.36
HPGD P15428 6/20 0.36
NTSR1 P30989 1/20 0.36
LMNA P02545 2/20 0.36
GLA P06280 1/20 0.36
PTGER4 P35408 1/20 0.35
MAPK1 P28482 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9889996 0.98 KDM4E (0.40) KDM4EL3MBTL1ATMMAPTMEN1
SCHEMBL24216404 0.96 KDM4E (0.38) KDM4EL3MBTL1ATMMAPTMEN1
SCHEMBL26356086 0.96 KDM4E (0.38) KDM4EL3MBTL1ATMMAPTMEN1
SCHEMBL9890004 0.95 KDM4E (0.39) KDM4EL3MBTL1ATMMAPTMEN1
SCHEMBL24216395 0.94 KDM4E (0.43) KDM4EL3MBTL1ATMMAPTMEN1
SCHEMBL26356088 0.94 KDM4E (0.40) KDM4EL3MBTL1ATMMAPTMEN1
SCHEMBL9889999 0.92 KDM4E (0.41) KDM4EL3MBTL1ATMMAPTMEN1
SCHEMBL9890073 0.92 MEN1 (0.39) KDM4EL3MBTL1ATMMAPTMEN1
SCHEMBL9890000 0.92 KDM4E (0.38) KDM4EL3MBTL1ATMMAPTMEN1
SCHEMBL21964881 0.92 KDM4E (0.38) KDM4EL3MBTL1ATMMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20100314644-A1 ORGANIC ELECTROLUMINESCENT DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 KDM4E 990/4885L3MBTL1 709/4885ATM 3103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.